For researchers looking to develop a vaccine to prevent Group B streptococcus (GBS) disease in infants, the May 17 meeting of US FDA's Vaccines and Related Biological Products Advisory Committee was a significant step forward.
The committee was asked to discuss possible endpoints to demonstrate effectiveness of GBS vaccines in preventing infant disease through maternal...







